Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 325 participants.

Also called NCT01699737

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 325 participants (enrolled count) (from the registry)
Sponsor
Shionogi Inc. (from the registry)
Registry
  • NCT NCT01699737
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01699737. Randomized; quadruple masking; primary purpose treatment. Start 2012-09 (registry gives no type); primary completion 2013-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
JTT-851
Intervention (Drug)
Glimepiride
Intervention (Drug)
Placebo for Active
Intervention (Drug)
Placebo for comparator
Lead sponsor
Shionogi Inc. (class: industry)

Record details

Record id
cardio:ct-nct01699737
Content hash
c7096b056545b0e6c89563c190501e51d85ceb4fcb3b0118635be16213748c82